Search for: "Astrazeneca LP" Results 1 - 20 of 138
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2010, 7:43 am by fraudfighters
Department Of Justice announced that it has entered into an agreement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to settle a False Claims Act lawsuit alleging that the companies submitted claims for payment to U.S. government health agencies (such as Medicare, Medicaid, and TRICARE) in connection with a scheme to illegally market the anti-psychotic drug Seroquel for uses that were not approved as safe and effective by the Food and Drug… [read post]
11 Feb 2015, 9:36 am by Mark Schlein
Pharmaceutical manufacturer AstraZeneca LP has agreed to pay $7.9 million to resolve allegations that the company paid kickbacks in the form of price concessions to a pharmacy benefit manager. [read post]
13 Feb 2015, 12:00 pm by Greene LLP
AstraZeneca LP et al. was filed under seal on behalf of the federal government in October 2010 by former AstraZeneca employees Paul DiMattia and F. [read post]
28 Jun 2016, 9:13 am by FDABlog HPM
(“iPR”), the owner of NDA 021366 for CRESTOR (rosuvastatin calcium) Tablets, 5 mg, 10 mg, 20 mg, and 40 mg, and AstraZeneca Pharmaceuticals LP (“AstraZeneca”), iPR’s agent, filed a Complaint in the U.S. [read post]
11 Feb 2015, 2:11 pm by Jeffrey A. Newman
According to the Department of Justice, AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, has agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced today. [read post]
27 Jun 2010, 9:11 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
16 Aug 2009, 9:58 pm
Astrazeneca LP et al. v. [read post]
27 Oct 2013, 9:55 pm by Patent Docs
Lupin Ltd. et al. 3:13-cv-06315; filed October 23, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Astrazeneca LP; KBI-E Inc.; Pozen, Inc. [read post]
8 Dec 2013, 8:02 pm by Patent Docs
Aurobindo Pharma Ltd. et al. 3:13-cv-07298; filed December 3, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
23 Nov 2010, 1:00 am by Jason Rantanen
By Jason Rantanen In an earlier post, I summarized the Federal Circuit's affirmance of a preliminary injunction prohibiting Apotex from marketing its generic version of AstraZeneca's budesonide in AstraZeneca LP v. [read post]
25 Mar 2012, 9:25 pm by Patent Docs
Mylan Laboratories Ltd, et al. 3:12-cv-01378; filed March 6, 2012 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI... [read post]
17 Nov 2014, 9:59 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
26 Oct 2014, 9:17 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]